Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor (Q21195751)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor |
scientific article |
Statements
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor (English)
0 references
Annelieke ECAB Willemsen
Annelieke ECAB
Willemsen
1 reference
1 reference
Pieter Wesseling
Pieter
Wesseling
1 reference
Heidi VN
Küsters-Vandevelde
Heidi Vn Küsters-Vandevelde
1 reference
1 reference
Patricia Jta Groenen
1 reference
Melika Djafarihamedani
1 reference
Jos Rijntjes
1 reference
Hans Delye
1 reference
Michel A Willemsen
1 reference
Carla Ml van Herpen
1 reference
Willeke Am Blokx
1 reference
2014
0 references
2
0 references
1
0 references
41
0 references
1 reference
1 reference
1 reference
1 reference